How to cross immunogenetic hurdles to human embryonic stem cell transplantation (Q37860986)

24 August 2017

1 reference

title

How to cross immunogenetic hurdles to human embryonic stem cell transplantation (English)

1 reference

stem cell transplantation

24 August 2017

main subject

1 reference

human embryonic stem cell

inferred from title

1 reference

Casimir de Rham

1

1 reference

24 August 2017

Jean Villard

series ordinal

2

1 reference

24 August 2017

publication date

2 April 2011

1 reference

Seminars in Immunopathology

24 August 2017

published in

1 reference

24 August 2017

volume

33

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

525-534

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-011-0262-z

24 August 2017

exact match

0 references

cites work

Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Human embryonic stem cells possess immune-privileged properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Immune influence on adult neural stem cell regulation and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Characterization of the expression of MHC proteins in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Stem cell medicine encounters the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Tolerance strategies for stem-cell-based therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Survival of priceless cells: active and passive protection of embryonic stem cells against immune destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Immunologic hurdles of therapeutic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Stem-cell-based therapy and lessons from the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Immunosuppressive drugs for kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Characterization of human embryonic stem cell lines by the International Stem Cell Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Cyclosporin A has direct effects on adult neural precursor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Immunoregulatory function of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Mixed chimerism and transplant tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Journey through the thymus: stromal guides for T-cell development and selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

HLA-mismatched renal transplantation without maintenance immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Nuclear reprogramming to a pluripotent state by three approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Oct4-induced pluripotency in adult neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Good manufacturing practice and clinical-grade human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

The derivation of clinical-grade human embryonic stem cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Experience of microbiological screening of human hepatocytes for clinical transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Human embryonic stem cells: origins, characteristics and potential for regenerative therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

HLA-matching potential of an established human embryonic stem cell bank in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

HLA-haplotype banking and iPS cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Enrichment of neurons and neural precursors from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Generation of Hepatocyte-Like Cells from Human Embryonic Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-011-0262-Z

Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching

21 January 2018

1 reference

12 December 2020

MULTIPOTENTIALITY OF SINGLE EMBRYONAL CARCINOMA CELLS

1 reference

12 December 2020

Lack of HLA class I and class II antigens on human preimplantation embryos

1 reference

12 December 2020

Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors

1 reference

12 December 2020

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

12 December 2020

FDA regulation of stem cell-based products

1 reference

12 December 2020

The George Hitchings and Gertrude Elion Lecture. The pharmacology of azathioprine.

1 reference

12 December 2020

A fresh look at iPS cells

1 reference

12 December 2020

10.1007/S00281-011-0262-Z

Identifiers

DOI

1 reference

24 August 2017

1 reference